Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term PROTEIN-KINASE. Found 14 abstracts

Damianova R, Stefanova N, Cukierman E, Momchilova A, Pankov R. Three-dimensional matrix induces sustained activation of ERK1/2 via Src/Ras/Raf signaling pathway. Cell biology international. 2008 Feb;32(2):229-34.
Jiang D, Guo HT, Xu CX, Chang JH, Gu BH, Wang LJ, Block TM, Guo JT. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. Journal of Virology. 2008 Feb;83(4):1665-78.
Mao K, Kobayashi S, Jaffer ZM, Huang Y, Volden P, Chernoff J, Liang QR. Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes. Journal of molecular and cellular cardiology. 2008 Feb;44(2):429-34.
Smith SD, Jaffer ZM, Chernoff J, Ridley AJ. PAK1-mediated activation of ERK1/2 regulates lamellipodial dynamics. Journal of cell science. 2008 Nov;121(22):3729-36.
Bell DW, Kim SH, Godwin AK, Schiripo TA, Harris PL, Haserlat SM, Wahrer DC, Haiman CA, Daly MB, Niendorf KB, Smith MR, Sgroi DC, Garber JE, Olopade OI, Le Marchand L, Henderson BE, Altshuler D, Haber DA, Freedman ML. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. International journal of cancer. 2007 Dec;121(12):2661-7.
Lee CH, Inoki K, Karbowniczek M, Petroulakis E, Sonenberg N, Henske EP, Guan KL. Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO Journal. 2007 Nov;26(23):4812-23.
Mao CC, Tili EG, Dose M, Haks MC, Bear SE, Maroulakou I, Horie K, Gaitanaris GA, Fidanza V, Ludwig T, Wiest DL, Gounari F, Tsichlis PN. Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. Journal of Immunology. 2007 May;178(9):5443-53.
Astsaturov I, Cohen RB, Harari PM. EGFR-targeting monoclonal antibodies in head and neck cancer. Current Cancer Drug Targets. 2006 Dec;6(8):691-710.
Neri LM, Borgatti P, Tazzari PL, Bortul R, Cappellini A, Tabellini G, Bellacosa A, Capitani S, Martelli AM. The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. Molecular Cancer Research. 2003 Jan;1(3):234-46.
Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, Fusco A, Santoro M. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nature medicine. 2002 Oct;8(10):1136-44.
De Vita G, Berlingieri MT, Visconti R, Castellone MD, Viglietto G, Baldassarre G, Zannini M, Bellacosa A, Tsichlis PN, Fusco A, Santoro M. Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects. Cancer Research. 2000 Jul;60(14):3916-20.
Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase Akt-dependent pathway. Journal of Biological Chemistry. 1998 Nov;273(45):29864-72.
Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM, Vogt PK. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (New York, NY). 1997 Jun;276(5320):1848-50.
Datta K, Bellacosa A, Chan TO, Tsichlis PN. Akt is a direct target of the phosphatidylinositol 3-kinase - Activation by growth factors, v-src and v-Ha-ras, in Sf9 and mammalian cells. Journal of Biological Chemistry. 1996 Nov;271(48):30835-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term PROTEIN-KINASE

PROTEIN-KINASE EXPRESSION GENE-EXPRESSION GROWTH-FACTOR PHOSPHORYLATION CELL-MIGRATION GENE SIGNAL-TRANSDUCTION TUMOR-SUPPRESSOR ACTIVATION PHOSPHATIDYLINOSITOL 3-KINASE CELL-SURVIVAL ANTIVIRAL PATHWAY BETA LINEAGE THYMOCYTES NF-KAPPA-B HUMAN BREAST-CANCER TUMOR FOCAL ADHESION KINASE LUNG-CANCER AKT DEPENDENT KINASE ALPHA-INTERFERON PAK1 RAC TUBEROUS SCLEROSIS PHASE-II MULTICENTER LOCALLY ADVANCED HEAD Extracellular matrix SQUAMOUS-CELL CARCINOMA P21-activated kinase PKB-cardiomyocytes RISK Src CARCINOMAS Akt TYROSINE SUBCELLULAR-LOCALIZATION P21-ACTIVATED KINASE EPITHELIAL-CELLS head and neck squamous cell cancer CANCER CELLS TYROSINE KINASE ASSOCIATION RHEB antibodies cetuximab AVIAN-SARCOMA ALPHA p53 EPIDERMAL-GROWTH-FACTOR Cell adhesion 2-Cell migration-Macrophages-Rho GTPases PP60C-SRC PROTOONCOGENE SUPPRESSION TRANSDUCTION ERK1 PAK1 PROMYELOCYTIC LEUKEMIA RADICAL SAM ENZYMES T-CELL DEVELOPMENT SITES EGFR HOMOLOGY HEREDITARY BREAST-CANCER HUMAN TUMOR XENOGRAFTS FHA DOMAIN ONCOGENES APOPTOTIC HL-60 CELLS COLLAGEN-MATRIX OLIGONUCLEOTIDE ARRAYS NUCLEAR MATRIX DIFFERENTIATION GROWTH-FACTOR-RECEPTOR TRANSCRIPTION FACTOR MACROPHAGE S-ADENOSYLMETHIONINE TRANSLATION INITIATION apoptosis MUTATION ANALYSIS DNA-DAMAGE CHECKPOINT AKT ACTIVATION MICE CELLS Ras PROSTATE-CANCER INITIATION-FACTOR 4E GENE-PRODUCTS RAPAMYCIN monoclonal CHEK2-ASTERISK-1100DELC DOMAIN CRYSTAL-STRUCTURE INDUCED mTOR MESSENGER-RNA HERBIMYCIN-A RAS C-SRC COPY NUMBER CELLULAR-SURVIVAL BETA-PIX C-MYB CDK-INHIBITORS TRANSCRIPTION FACTORS EPITHELIAL-CELL LINE MYOCYTES DEVELOPMENTAL PROGRESSION susceptibility cHEK2-breast-cancer-mutation SINGLE-STRANDED RNA Three-dimensional matrix CARDIAC GROWTH PC12 CELLS PHOSPHATIDYLINOSITOL KINASE-ACTIVITY ANAPLASTIC THYROID-CANCER BRCA1 MUTATIONS MAMMALIAN TARGET RAF-1 VIRUS HEPATOCELLULAR-CARCINOMA ONCOGENE DEPENDENT rapamycin Fibronectin ALPHA-BETA GROWTH ERK P27 GAP ACTIVITY INHIBITOR P70S6 KINASE IMMATURE THYMOCYTES RECEPTOR NERVE GROWTH-FACTOR RENAL ANGIOMYOLIPOMAS SIGNALING PATHWAY PAXILLIN PHOSPHORYLATION HUMAN CYTOMEGALOVIRUS PHOSPHOINOSITIDE 3-KINASE radiation APOPTOSIS
Last updated on Friday, August 14, 2020